Parallax Volatility Advisers
TEVA icon

Parallax Volatility Advisers’s Teva Pharmaceuticals TEVA Stock Holding History

Parallax Volatility Advisers’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-361,000
Closed -$11.3M – 1828
2025
Q4 		$11.3M Buy
361,000
+245,000
+211% +$6.04M 0.02% 424
2025
Q3 		$2.34M Sell
116,000
-10,000
-8% -$176K ﹤0.01% 876
2025
Q2 		$2.11M Hold
126,000
– – ﹤0.01% 868
2025
Q1 		$1.94M Sell
126,000
-743,100
-86% -$13.3M 0.01% 876
2024
Q4 		$19.2M Buy
869,100
+419,000
+93% +$7.62M 0.04% 357
2024
Q3 		$8.11M Hold
450,100
– – 0.01% 622
2024
Q2 		$7.31M Buy
450,100
+450,000
+450,000% +$6.93M 0.02% 583
2024
Q1 		$1.41K Sell
100
-1,405,100
-100% -$17.7M ﹤0.01% 1721
2023
Q4 		$14.7M Buy
1,405,200
+205,300
+17% +$1.92M 0.03% 477
2023
Q3 		$12.2M Sell
1,199,900
-18,400
-2% -$171K 0.03% 477
2023
Q2 		$9.17M Sell
1,218,300
-95,500
-7% -$774K 0.02% 565
2023
Q1 		$11.6M Sell
1,313,800
-836,200
-39% -$8.27M 0.02% 537
2022
Q4 		$19.6M Buy
2,150,000
+310,200
+17% +$2.71M 0.03% 534
2022
Q3 		$14.8M Buy
1,839,800
+1,190,100
+183% +$10.5M 0.02% 630
2022
Q2 		$4.88M Sell
649,700
-69,900
-10% -$609K ﹤0.01% 986
2022
Q1 		$6.76M Sell
719,600
-402,300
-36% -$3.36M ﹤0.01% 881
2021
Q4 		$8.99M Buy
1,121,900
+139,000
+14% +$1.25M 0.01% 628
2021
Q3 		$9.57M Buy
982,900
+328,500
+50% +$3.08M 0.01% 658
2021
Q2 		$6.48M Buy
654,400
+424,400
+185% +$4.49M 0.01% 601
2021
Q1 		$2.65M Sell
230,000
-901,800
-80% -$10.3M 0.01% 627
2020
Q4 		$10.9M Buy
1,131,800
+276,000
+32% +$2.64M 0.01% 698
2020
Q3 		$7.71M Sell
855,800
-499,100
-37% -$5.28M 0.01% 1117
2020
Q2 		$16.7M Sell
1,354,900
-55,400
-4% -$627K 0.02% 584
2020
Q1 		$12.7M Buy
1,410,300
+717,300
+104% +$7.35M 0.02% 526
2019
Q4 		$6.79M Sell
693,000
-196,500
-22% -$1.75M 0.01% 784
2019
Q3 		$6.12M Buy
889,500
+285,300
+47% +$2.19M 0.01% 744
2019
Q2 		$5.58M Buy
604,200
+221,200
+58% +$2.67M 0.01% 690
2019
Q1 		$6.01M Buy
383,000
+272,600
+247% +$4.81M 0.01% 630
2018
Q4 		$1.7M Sell
110,400
-186,000
-63% -$3.81M ﹤0.01% 1111
2018
Q3 		$6.38M Buy
296,400
+171,400
+137% +$3.98M 0.01% 631
2018
Q2 		$3.04M Sell
125,000
-2,817,200
-96% -$57.5M ﹤0.01% 782
2018
Q1 		$50.3M Buy
2,942,200
+1,847,200
+169% +$36.1M 0.07% 135
2017
Q4 		$20.8M Buy
1,095,000
+845,000
+338% +$12.7M 0.03% 252
2017
Q3 		$4.4M Buy
+250,000
New +$5.63M 0.01% 598
2017
Q1 		– Sell
-117,000
Closed -$4.24M – 4613
2016
Q4 		$4.24M Buy
117,000
+37,000
+46% +$1.48M 0.01% 691
2016
Q3 		$3.68M Buy
+80,000
New +$4.17M 0.01% 797
2016
Q1 		– Sell
-235,000
Closed -$15.4M – 3645
2015
Q4 		$15.4M Buy
235,000
+225,000
+2,250% +$13.9M 0.03% 337
2015
Q3 		$565K Hold
10,000
– – ﹤0.01% 1488
2015
Q2 		$591K Buy
+10,000
New +$617K ﹤0.01% 1549
2015
Q1 		– Sell
-111,500
Closed -$6.41M – 5500
2014
Q4 		$6.41M Hold
111,500
– – 0.02% 611
2014
Q3 		$6M Sell
111,500
-36,700
-25% -$1.94M 0.02% 647
2014
Q2 		$7.77M Sell
148,200
-41,900
-22% -$2.14M 0.03% 376
2014
Q1 		$10M Buy
+190,100
New +$8.79M 0.06% 255

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallax Volatility Advisers's TEVA Position: Q1 2026 in Review

Parallax Volatility Advisers sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 117,708 shares — an estimated $3.67M sold.

Parallax Volatility Advisers first reported a position in TEVA in Q1 2014 and held it in 38 quarters. The position peaked at $25M in Q4 2024. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Parallax Volatility Advisers reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 117,708 Teva Pharmaceuticals shares in Q1 2026, an estimated $3.67M.
  • Parallax Volatility Advisers first reported a position in Teva Pharmaceuticals in Q1 2014 and held it in 38 quarters.
  • Parallax Volatility Advisers's Teva Pharmaceuticals position peaked at $25M in Q4 2024.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Parallax Volatility Advisers's 13F filing for Q1 2026, filed 15 May 2026.